Hong Zhao

Hong Zhao is a declared insider of Sciclone Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 25 filings cover trades dated from 14 May 2014 to 13 October 2017.

On the market, this insider has only sold: 11 sales, €1.3M in total. Besides market trades, the filings include 1 share grant and 12 option exercises. Since January 2017: no purchases and 5 sales on the market.

On 16 October 2017 came the latest disclosure, an option exercise in Sciclone Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.